Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Ajeet Gajra, MD FACP, Marjorie E Zettler, PhD MPH, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Sonam Mehta, Bruce Feinberg, DO

Blood (2019) 134 (Supplement_1): 1952.

https://doi.org/10.1182/blood-2019-129593

Published: 2019

Journal Articles

Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Myeloma Receiving Daratumumab and Pomalidomide

Jorge Monge, MD, Jorge Contreras, MD, Sarah Elsoukkary, MD, Jin Guo, MD, Art Perry, PA, Robin S. Solomon, Kari Flicker, BS, David S Jayabalan, MSc, Morton Coleman, MD, Adriana C. Rossi, MDMSc, Rebecca Harris, MD, Markus Plate, MD, Joerg-Patrick Stuebgen, MB, ChB, MD, Ruben Niesvizky, MD

Blood (2019) 134 (Supplement_1): 4876.

https://doi.org/10.1182/blood-2019-122134

Published: 2019

Journal Articles

Cerebral Thrombosis As an Initial Presentation of Pediatric Acute Promyelocytic Leukemia

Selin Aytac, MD, Cagrı Coskun, MD, Tekin Aksu, MD, Baris Kuskonmaz

Blood (2019) 134 (Supplement_1): 5116.

https://doi.org/10.1182/blood-2019-127958

Published: 2019

Journal Articles

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Sangeetha Gandhi, MBBS, N. Nora Bennani, MD, Sonia Fortin, Thomas M. Habermann, MD, Patrick Johnston, MD, James R. Cerhan, MD PhD, Kay M. Ristow, BS, Carrie A. Thompson, MD, Grzegorz Nowakowski, MD, Yi Lin, MD PhD, Jose C Villasboas, MD, Luis Porrata, MD, Thomas E. Witzig, MD, Ivana Micallef, MD, David J Inwards, MD, Stephen M Ansell, MD PhD, Jonas Paludo, MD

Blood (2019) 134 (Supplement_1): 5293.

https://doi.org/10.1182/blood-2019-131965

Published: 2019

Journal Articles

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Sarah Bryant, BS, Ian Moore, PhD, Bianca Nagata, Danielle Springer, VMD, DACLAM, Audrey Noguchi, Morteza Peiravi, Karlie Sharma, PhD, Sherry M. Koontz, Harry Malech, MD, Elizabeth Kang, MD

Blood (2017) 130 (Supplement 1): 3172.

https://doi.org/10.1182/blood.V130.Suppl_1.3172.3172

Published: 2017

Journal Articles

Thromboembolic and Vascular Complications in Patients with Secondary Erythrocytosis Caused By High Oxygen Affinity Variant Hb Coimbra

Bruna Cunha Santos, Susan Elisabeth Jorge, BS, PhD, Dulcinéia Martins de Albuquerque, Simone Cristina Olenscki Gilli, MD PhD, Maria de Fátima Sonati, Kleber Yotsumoto Fertrin, MD PhD, Fernando Ferreira Costa, MD PhD

Blood (2017) 130 (Supplement 1): 3526.

https://doi.org/10.1182/blood.V130.Suppl_1.3526.3526

Published: 2017

Journal Articles

Bing-Neel Syndrome at Diagnosis of Waldenstrom: An Extremely Rare Case Report

Dionisios Stoumbos, MD, Ioannis Patsias, MD, Evaggelos Asmanis, MD, Evangelia Eleni Christaki, MD, Katsiva Vailiki, MD, Anna Tasidou, MD, Marie-Christine Kyrtsonis, MD, Panagiotis Repousis, MD, Maria Kotsopoulou, MD

Blood (2015) 126 (23): 5065.

https://doi.org/10.1182/blood.V126.23.5065.5065

Published: 2015

Journal Articles

A Retrospective Multicenter Study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO) on Cerebral Sinus Venous Thromboses in Children with Acute Lymphoblastic Leukemia

Susanna Ranta, Nadine Gretenkort Andersson, Ulf R. Tedgard, Tony Frisk, Maria Winther Gunnes, Jon Helgestad, Ólafur G Jónsson, MD, Birgitte Klug Albertsen, Anne Mäkipernaa, Kaie Pruunsild, Mats Heyman, MD PhD, Thomas Leth Frandsen, Sonata Trakymiene, Ellen Ruud, Ruta Tuckuviene

Blood (2014) 124 (21): 584.

https://doi.org/10.1182/blood.V124.21.584.584

Published: 2014

Journal Articles

A Modified Dose Intensive R- CODOX-M/IVAC For HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL) Demonstrates High Cure Rates and Low Toxicity: Prospective Multicenter Phase II Trial Of The AIDS Malignancy Consortium (AMC 048)

Ariela Noy, MD, Lawrence Kaplan, MD, Jeannette Y Lee, Ph.D.

Blood (2013) 122 (21): 639.

https://doi.org/10.1182/blood.V122.21.639.639

Published: 2013

Journal Articles

Breakthrough Stroke During Rivaroxaban Therapy in a Patient with Non-Valvular Atrial Fibrillation

Inhye E Ahn, MD, Myungsun Kim, MD

Blood (2012) 120 (21): 4370.

https://doi.org/10.1182/blood.V120.21.4370.4370

Published: 2012

Journal Articles

Ischemic Stroke in Young Patients with Cardiac Abnormalities and Hypercoagulable State: 2 Case Reports and Literature Review to Assess Diagnostic and Prevention Options

Lisa Thomas, MD, Qi Shi, MD, Arjinder Sethi, MD, Sathyanarayanan Ramakrishnan, MD, Jihua Jia, MD, Linda Thomas-Hemak, MD

Blood (2011) 118 (21): 4663.

https://doi.org/10.1182/blood.V118.21.4663.4663

Published: 2011

Journal Articles

Is Multiple Sclerosis a Risk for Hypercoagulation States or Breast Cancer? A Case Report and a Literature Review to Assess Options

Lisa Thomas, MD, Qi Shi, MD, Sathyanarayanan Ramakrishnan, MD, Jihua Jia, MD, Linda Thomas-Hemak, MD

Blood (2011) 118 (21): 4665.

https://doi.org/10.1182/blood.V118.21.4665.4665

Published: 2011

Journal Articles

Methotrexate and Temozolomide Plus Intrathecal Liposomal Cytarabine for Primary or Secondary Central Nervous System Lymphoma

Lorenzo Falchi, Marco Gunnellini, Ilaria Angeletti, Laura Franco, Anna Marina Liberati

Blood (2010) 116 (21): 4899.

https://doi.org/10.1182/blood.V116.21.4899.4899

Published: 2010

Journal Articles

Management Strategies of Stroke and Acute Coronary Syndrome In Von Willebrand Disease and Hemophilia: Experience From a Case Series and a Swiss Survey of Frequencies.

Sara C. Meyer, MD, PhD, Elina Armstrong, MD, PhD, Christine Perdrizat, Hans-Rudolf Schmid, PhD, Riitta Lassila, MD, PhD, Juerg H. Beer, MD

Blood (2010) 116 (21): 1406.

https://doi.org/10.1182/blood.V116.21.1406.1406

Published: 2010

Journal Articles

Spurious pleocytosis

Blood (2010) 116 (5): 678.

https://doi.org/10.1182/blood-2009-10-245720

Published: 2010

Journal Articles

Feasibility and Toxicity of a Modified Dose Intensive R- CODOX-M/IVAC for HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL): Preliminary Results of a Prospective Multicenter Phase II Trial of the AIDS Malignancy Consortium (AMC).

Ariela Noy, MD, Lawrence Kaplan, MD, Jeannette Lee

Blood (2009) 114 (22): 3673.

https://doi.org/10.1182/blood.V114.22.3673.3673

Published: 2009

Journal Articles

Adding Hydroxyurea to Chronic Transfusion Therapy for Stroke in Sickle Cell Disease.

Susan Claster, MD, Keith C. Quirolo, MD

Blood (2009) 114 (22): 4620.

https://doi.org/10.1182/blood.V114.22.4620.4620

Published: 2009

Journal Articles

Veno-Occlusive Disease of the Liver during Induction Therapy for Acute Lymphoblastic Leukemia

Athanasios Papadopoulos, Sr., George Ntaios, Georgia Kaiafa, Fotios I Girtovitis, Zoi Saouli, Zisis Kontoninas, Michael D. Diamantidis, Charalambos Andreadis, Christos Savopoulos, Apostolos Hatzitolios

Blood (2008) 112 (11): 3949.

https://doi.org/10.1182/blood.V112.11.3949.3949

Published: 2008

Journal Articles

Antecedent Transfusion and Primary Hemorrhagic Stroke in Adults with Sickle Cell Disease.

John J. Strouse, MD, Joshua Field, MD, Regina D. Crawford, M.D., Sophie Lanzkron, MD

Blood (2008) 112 (11): 1437.

https://doi.org/10.1182/blood.V112.11.1437.1437

Published: 2008

Journal Articles

Antibodies Targeting Subunit 1 of the N -Methyl-D-Aspartate Receptor May Contribute to Immune Mediated Thrombocytopenia.

Maggie L. Kalev-Zylinska, MD, PhD, FRCPA, Hilary A. Blacklock, Gordon Royle, Ross Henderson, Peter Flanagan, Sharon Jackson, Isuru Dilshan, Wymond Symes, Kathryn Goldstone, Peter Browett, Matthew J. During

Blood (2007) 110 (11): 2110.

https://doi.org/10.1182/blood.V110.11.2110.2110

Published: 2007

NARROW

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Myeloma Receiving Daratumumab and Pomalidomide

Cerebral Thrombosis As an Initial Presentation of Pediatric Acute Promyelocytic Leukemia

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Thromboembolic and Vascular Complications in Patients with Secondary Erythrocytosis Caused By High Oxygen Affinity Variant Hb Coimbra

Bing-Neel Syndrome at Diagnosis of Waldenstrom: An Extremely Rare Case Report

A Retrospective Multicenter Study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO) on Cerebral Sinus Venous Thromboses in Children with Acute Lymphoblastic Leukemia

A Modified Dose Intensive R- CODOX-M/IVAC For HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL) Demonstrates High Cure Rates and Low Toxicity: Prospective Multicenter Phase II Trial Of The AIDS Malignancy Consortium (AMC 048)

Breakthrough Stroke During Rivaroxaban Therapy in a Patient with Non-Valvular Atrial Fibrillation

Ischemic Stroke in Young Patients with Cardiac Abnormalities and Hypercoagulable State: 2 Case Reports and Literature Review to Assess Diagnostic and Prevention Options

Is Multiple Sclerosis a Risk for Hypercoagulation States or Breast Cancer? A Case Report and a Literature Review to Assess Options

Methotrexate and Temozolomide Plus Intrathecal Liposomal Cytarabine for Primary or Secondary Central Nervous System Lymphoma

Management Strategies of Stroke and Acute Coronary Syndrome In Von Willebrand Disease and Hemophilia: Experience From a Case Series and a Swiss Survey of Frequencies.

Spurious pleocytosis

Feasibility and Toxicity of a Modified Dose Intensive R- CODOX-M/IVAC for HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL): Preliminary Results of a Prospective Multicenter Phase II Trial of the AIDS Malignancy Consortium (AMC).

Adding Hydroxyurea to Chronic Transfusion Therapy for Stroke in Sickle Cell Disease.

Veno-Occlusive Disease of the Liver during Induction Therapy for Acute Lymphoblastic Leukemia

Antecedent Transfusion and Primary Hemorrhagic Stroke in Adults with Sickle Cell Disease.

Antibodies Targeting Subunit 1 of the N -Methyl-D-Aspartate Receptor May Contribute to Immune Mediated Thrombocytopenia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only